Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) EPS (Basic): 2019-2024

Historic EPS (Basic) for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to -$1.65.

  • Caribou Biosciences' EPS (Basic) rose 21.05% to -$0.30 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.70, marking a year-over-year decrease of 2.41%. This contributed to the annual value of -$1.65 for FY2024, which is 19.57% down from last year.
  • As of FY2024, Caribou Biosciences' EPS (Basic) stood at -$1.65, which was down 19.57% from -$1.38 recorded in FY2023.
  • Caribou Biosciences' 5-year EPS (Basic) high stood at -$1.38 for FY2023, and its period low was -$4.01 during FY2020.
  • For the 3-year period, Caribou Biosciences' EPS (Basic) averaged around -$1.56, with its median value being -$1.64 (2022).
  • In the last 5 years, Caribou Biosciences' EPS (Basic) slumped by 43.21% in 2020 and then soared by 47.38% in 2021.
  • Yearly analysis of 5 years shows Caribou Biosciences' EPS (Basic) stood at -$4.01 in 2020, then surged by 47.38% to -$2.11 in 2021, then rose by 22.27% to -$1.64 in 2022, then climbed by 15.85% to -$1.38 in 2023, then decreased by 19.57% to -$1.65 in 2024.